Scholar Rock Holding Corp

NASDAQ:SRRK

29.86

-1.94 (-6.10%)

Market Cap (Intraday)	963.25M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$5.8 Million
Adjusted EPS	-$0.65

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Scholar Rock Holding Corp. Stock, NASDAQ:SRRK

620 Memorial Drive, 2nd floor, Cambridge, Massachusetts 02139

United States of America

Phone: +1.857.259.3860

Number of Employees: 93

http://www.scholarrock.com

Description

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.